TCRCure Biopharma
PrivateLast Round
Series B
Feb 16, 2022
Total Funding Raised
$47.3M
Company Overview
TCRCure is a biotechnology company specializing in the development of cancer immunotherapies through advanced techniques such as high throughput antigen-specific TCR cloning, large-scale virus production, T cell genetic engineering, and immune cell manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TCRCure Biopharma Comps
Public and private peers based on sector, stage, and business model.
TCRCure Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 16, 2022 | ||||
| Series B | Dec 28, 2018 | ||||
| Series A | Apr 1, 2018 |
TCRCure Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emerging Technology Partners | Series B |
| CCB Financial Assets Investment | Series B |
| 德同资本 | Series B |
| Share Capital | Series B |
| Founder Hesheng Investment Co., Ltd. | Series B |
TCRCure Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TCRCure Biopharma's valuation, stock price, and market status.
